Opaleye Management Inc. Mei Pharma, Inc. Transaction History

Opaleye Management Inc.

  • $548 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$0.54 - $2.74 $710,100 - $3.6 Million
-1,315,000 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$2.33 - $3.37 $582,500 - $842,500
-250,000 Reduced 15.97%
1,315,000 $3.51 Million
Q2 2021

Aug 16, 2021
BUY
$2.6 - $3.65 $23,400 - $32,850
9,000 Added 0.58%
1,565,000 $4.46 Million
Q2 2020

Aug 14, 2020
BUY
$1.45 - $4.3 $2.26 Million - $6.69 Million
1,556,000 New
1,556,000 $6.43 Million

Others Institutions Holding MEIP

# of Institutions
1
Shares Held
2K
Call Options Held
0
Put Options Held
0
View Full List

About MEI Pharma, Inc.

MEIP Quotes by TradingView
  • Ticker MEIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 133,261,000
  • Market Cap $318M
  • Description
  • MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...
More about MEIP
Track This Portfolio

Track Opaleye Management Inc. Portfolio

Follow Opaleye Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Opaleye Management Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email